Ceres Pharma

Merelbeke, Belgium Founded: 2017 • Age: 9 yrs Acquired By Naxicap
Nutritional supplements are manufactured and marketed by Ceres Pharma.

About Ceres Pharma

Ceres Pharma is a Healthcare company based in Merelbeke (Belgium) founded in 2017 by Marc Coucke and Mario Debel, and was acquired by Naxicap in June 2021. Nutritional supplements are manufactured and marketed by Ceres Pharma. The company has 31 employees. Ceres Pharma has completed 4 acquisitions, including AMNOL, Aesculapius and Ceumed. Its chief executive, as recorded, is Mario Debel. Ceres Pharma offers products and services including Prescription Drugs and Food Supplements. Its focus areas include Traditional Nutraceuticals and Dietary Supplements.

Company details

Ceres Pharma was established in 2017 in Merelbeke, Belgium, within the health and wellness sector. A variety of nutritional supplements is produced and distributed, covering categories like calcium support, joint care, fatigue management, sports nutrition, dietary aids, intestinal health, anti-stress formulas, and skin treatments. Distribution occurs through collaborations with retail outlets. The firm was co-founded by Marc Coucke and Mario Debel, who holds the CEO position.

  • Headquarters Merelbeke, Belgium
  • Employees 31
  • Founders Marc Coucke, Mario Debel
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website ceres-pharma.com/en
  • Social LinkedIn
  • Acquired by Naxicap (Jun 2021)
  • Legal Name Ceres Pharma
Key Metrics
  • Latest Funding Round
    $197.79K (USD), Grant

    Dec 2023

  • Investors
  • Employee Count
    31
  • Investments & Acquisitions
    AMNOL

    & 3 more

  • Acquired by
    Naxicap

    (Jun 2021)

Products & Services of Ceres Pharma

Ceres Pharma offers a comprehensive portfolio of products and services, including Prescription Drugs and Food Supplements.

Prescription Drugs
Pharmaceuticals

Development, production, and distribution of prescription drugs for women’s and family health are undertaken by Ceres Pharma

Food Supplements
Health Products

Production and distribution of food supplements and cosmetics for women’s and family health are carried out by Ceres Pharma

Funding Insights of Ceres Pharma

  • Total Rounds 1
  • Last Round Grant β€” $197,792
  • First Round $197,792

    (Dec 2023)

  • Investors Count 1

All 1 funding rounds of Ceres Pharma with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Dec 2023$197,792Grant––
Valuation history

2 investors in total: 2 institutional.

Investors in Ceres Pharma

Ceres Pharma has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union and Naxicap.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Investments in small and medium-sized businesses are managed by Naxicap.
naxicap.comFrankfurt Am Main, Germany
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
Premium access

Investor details for Ceres Pharma

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Ceres Pharma

19 people are tracked at Ceres Pharma (7 in leadership, 12 in team); the tracked headcount is 31.

NameRoleGroup
Marc Coucke
Co-FounderLeadership
Mario Debel
Co-Founder & CEOLeadership
Anja Imschoot
CFOLeadership
Chantal Poppe
International Marketing & Communication DirectorLeadership
Mike van Ganse
Chief Operating OfficerLeadership
Silvia Confalonieri
Head Of MarketingLeadership
Bavo Depoortere
International Head Of Graphics & WebLeadership
Charlotte Masschelein
ProductmanagerTeam
Bram van Peteghem
Corporate Project ManagerTeam
Pieter Vuyge
Corporate Legal Counsel At Ceres Pharma NVTeam
Bram Verschueren
Business ControllerTeam
Adnan Maghari
Group Business ControllerTeam
Jonas Vandeputte
Brand Assistant Etixx Sports NutritionTeam
Herlinde de Spiegeleer
Brand ActivatorTeam
Ingrid Lerno
RP GDPTeam
Cynthia Pots
SupplychainTeam
Stein Duquet
Finance & Operations ManagerTeam
Arne Aers
Brand ManagerTeam
Niels de Baecke
Trade & Digital Marketing ManagerTeam
Premium access

Complete people profiles for Ceres Pharma

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Ceres Pharma

Ceres Pharma has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include AMNOL, Aesculapius and Ceumed.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Pharmaceutical products, food supplements, and cosmetics are developed and sold.
aesculapius.itBrescia, Italy1959Jan 2024β€’β€’β€’β€’
Dermo-cosmetics products are manufactured by AMNOL in Italy.
amnol.netNovara, Italy1978May 2023β€’β€’β€’β€’
Plant-based healthcare supplements are offered via an online platform.
daciaplant.roBrasov, Romania2002Oct 2022β€’β€’β€’β€’
ceumed.com0Nov 2018β€’β€’β€’β€’
Premium access

Complete acquisition details for Ceres Pharma

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Ceres Pharma

7 dated milestones of Ceres Pharma across 7 years, from founding to its latest funding, stage changes and deals.

  1. Founded Ceres Pharma is founded.
  2. Acquisition Acquires Ceumed.
  3. Exit Acquired by Naxicap.
  4. Acquisition Acquires Dacia Plant.
  5. Acquisition Acquires AMNOL.
  6. Funding First funding round of $198K.
  7. Acquisition Acquires Aesculapius.

Web traffic of Ceres Pharma

The website of Ceres Pharma (ceres-pharma.com) receives about 3.8K visits a month.

  • Monthly visits
    3.8K

    ▲ 51.1% vs previous month

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Ceres Pharma

Ceres Pharma was founded in 2017 and raised its 1st funding round 6 years after it was founded.

Ceres Pharma is headquartered in Merelbeke, Belgium. It is registered at Merelbeke, East Flanders, Belgium.

Mario Debel is the CEO of Ceres Pharma, as recorded in our data. They have also founded this company.

Ceres Pharma has 31 employees.

Ceres Pharma was established in 2017 in Merelbeke, Belgium, within the health and wellness sector. A variety of nutritional supplements is produced and distributed, covering categories like calcium support, joint care, fatigue management, sports nutrition, dietary aids, intestinal health, anti-stress formulas, and skin treatments. Distribution occurs through collaborations with retail outlets. The firm was co-founded by Marc Coucke and Mario Debel, who holds the CEO position.

Ceres Pharma offers Prescription Drugs and Food Supplements.

Ceres Pharma has made 4 acquisitions, including AMNOL, Aesculapius, and Ceumed.

Ceres Pharma has 2 investors. Key investors include European Union, and Naxicap.

Ceres Pharma operates through Ceres Pharma.

Yes. Ceres Pharma was acquired by Naxicap in June 2021.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available